Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation develops and sells cannabis products for adult-use and medical markets, with common shares trading as CGC on Nasdaq and WEED on the TSX. Company updates frequently cover Canadian brand activity across Tweed, Deelish, 7ACRES, DOJA, Deep Space and related formats including flower, pre-rolls, vapes, softgels and minor cannabinoid products.
News also centers on medical cannabis services through Canada House Clinics and the Abba Medix online channel, Storz & Bickel vaporization devices, operating and financial results, capital-structure actions, shareholder voting matters and governance changes. Canopy Growth also discloses its unconsolidated, non-controlling interest in Canopy USA as exposure to the U.S. THC market.
Canopy Growth (Nasdaq: CGC) announced that its DOJA facility in Kelowna, BC is now operating exclusively as a medical cultivation site supporting the company's Spectrum Therapeutics portfolio as of October 8, 2025. The site will produce small-batch, BC-grown craft cannabis under the DOJA brand that will be available only to registered Spectrum Therapeutics medical patients, including veterans. The facility operates under a new micro-cultivation license and has been upgraded to deliver consistent, high-quality flower and support product development within Spectrum's medical lineup.
JP Brand Advisors and Canopy USA announced a strategic partnership on October 7, 2025 to expand U.S. distribution of Wana Wellness hemp-based beverages and gummies. The agreement assigns JP Brand Advisors to support distributor management and strategic account growth while leveraging Canopy USA's cannabis-market distribution footprint. The partnership targets growth in the non-alcoholic, functional and hemp-infused beverage segment amid rising retailer and distributor interest and greater regulatory clarity in key markets.
Canopy Growth (NASDAQ:CGC) has announced the adjournment of its Annual General and Special Meeting of Shareholders due to insufficient quorum. The meeting, originally scheduled for September 26, 2025, has been rescheduled to October 10, 2025 at 1:00 PM ET via live webcast.
The company requires 33 1/3% of outstanding shares to be represented for quorum, as per NASDAQ listing requirements. Shareholders of record as of August 1, 2025 are eligible to vote, and the voting deadline has been extended to October 8, 2025. The company has retained Laurel Hill Advisory Group to assist shareholders with the voting process.
Canopy Growth (NASDAQ:CGC) has extended the proxy voting deadline for its upcoming Annual General and Special Meeting to September 26, 2025 at 9:00 AM ET. The Meeting will be held the same day at 1:00 PM ET via live audio webcast. The extension aims to ensure a quorum of 33 1/3% of outstanding shares, required by NASDAQ listing rules.
CEO Luc Mongeau indicated they are close to achieving quorum and encouraged remaining shareholders to participate. The company has retained Laurel Hill Advisory Group to assist shareholders with voting, which can be done online, by phone, or through various platforms depending on where shares are held.
Canopy Growth (NASDAQ:CGC) is urging shareholders to vote ahead of their Annual General and Special Meeting scheduled for September 26, 2025. The company needs to reach a quorum threshold of 33 1/3% of outstanding shares to maintain its NASDAQ listing requirements and avoid meeting delays and additional costs.
Shareholders of record as of August 1, 2025 are eligible to vote, with a proxy voting deadline of September 24, 2025 at 1:00 PM ET. The Board of Directors recommends voting FOR all proposals. Multiple voting options are available through Broadridge, Interactive Brokers, Robinhood, or through the company's proxy solicitation agent, Laurel Hill Advisory Group.
Canopy Growth (Nasdaq: CGC) has appointed Tom Stewart as permanent Chief Financial Officer, effective immediately. Stewart, who has served as Interim CFO since July 2025 and has been part of the company's senior finance leadership since 2019, will focus on executing Canopy Growth's fiscal year 2026 strategy.
Under Stewart's interim leadership, the company has made progress in stabilizing its financial position through debt repayments, cost reduction initiatives, and capital raising via ATM programs. The appointment aligns with Canopy Growth's emphasis on operational discipline, financial stability, and long-term value creation.
Canopy Growth (Nasdaq: CGC) has completed an early prepayment of US$25 million on its senior secured term loan, following a previous US$25 million payment made on July 31, 2025. This fulfills the company's total prepayment obligations of US$50 million under the agreement with lenders announced on July 29, 2025.
The accelerated debt reduction is expected to result in US$6.5 million in annual cash interest savings, with US$4.0 million of cash interest savings specifically for fiscal 2026. The early completion of these prepayments demonstrates the company's commitment to strengthening its financial position through debt reduction and interest expense management.
STORZ & BICKEL, a subsidiary of Canopy Growth Corporation (NASDAQ: CGC), has launched the VEAZY, their most compact and accessible vaporizer to date. Priced at $249 USD, this new device marks the company's first entry into colorful design options, available in Charming Pink, Inspiring Orange, Dynamic Blue, and Alluring Black.
The VEAZY features advanced technology including a patented mini heater with conduction and convection capabilities, Bluetooth connectivity for personalized settings via a web app, and USB-C fast charging. At just 0.3lbs, the device offers three pre-set temperatures and heats up in approximately 40 seconds. The product will be distributed through online and select retail channels across more than 100 countries worldwide.
Canopy Growth (Nasdaq: CGC) has established a new US$200 million at-the-market (ATM) equity program to strengthen its financial position. The program allows the company to issue and sell common shares through concurrent public offerings in the United States and Canada, with Canadian sales limited to US$50 million.
The ATM program will be effective until June 5, 2027, or until the total offering amount is reached. Shares will be sold at prevailing market prices through BMO Nesbitt Burns Inc. (Canada) and BMO Capital Markets Corp. (USA). The proceeds will be used for business investments, potential acquisitions, working capital, and possible debt repayment.
Canopy USA (NASDAQ:CGC) has appointed Eric Ruhle as Vice President of Brand Sales to oversee sales strategy across its cannabis brand portfolio. Ruhle brings over 11 years of cannabis industry experience, most recently serving as Senior Regional Sales Manager at Kiva Sales & Services.
In his new role, Ruhle will focus on expanding retail presence, strengthening distributor partnerships, and launching go-to-market initiatives to drive revenue growth. His previous leadership positions at Marley Natural, dosist, and Final Bell demonstrate his expertise in scaling multi-brand portfolios and developing retail partnerships.